Clinical Trials in Ohio

Showing 13541-13560 of 17,983 trials

Sunitinib in Treating Patients With Relapsed or Refractory Esophageal or Gastroesophageal Junction Cancer

NCT00702884

RATIONALE: Sunitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. PURPOSE: This phase II trial is studying how well sunitinib works in treating patients with relapsed or refractory esophageal or gastroesophageal junction cancer.

Esophageal Cancer

Tony Bekaii-Saab25 participantsStarted Jun 2008

Columbus, Ohio, United States

TERMINATEDPhase 232 miles

Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil

NCT01712074

This study will evaluate safety and efficacy of PF-05212377 in subjects with mild-to-moderate Alzheimer's Disease with existing neuropsychiatric symptoms on a stable dose of Donepezil. The 4-week run-in will minimize placebo effect. The 12-week treatment period is considered the minimum length necessary to reliably evaluate the effect PF-05212377 on cognition and and neuropsychiatric symptoms in this population. The 2-week washout will allow to monitor re-emergence of neuropsychiatric and cognitive symptoms.

Alzheimer's Disease

Pfizer186 participantsStarted Nov 2012

Costa Mesa, California, United States • Imperial, California, United States • Rancho Mirage, California, United States +57 more locations

Sunitinib in Treating Patients With Relapsed or Refractory Esophageal or Gastroesophageal Junction Cancer

Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil

Find Trials by Condition in Ohio

A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLC

Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Safety and Efficacy of Turoctocog Alfa in Haemophilia A Subjects

Study of Safety of Foradil in Patients With Persistent Asthma

Natalizumab Re-Initiation of Dosing

Individualized Therapy For Asthma in Toddlers

A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients

A Study of LY2405319 in Participants With Type 2 Diabetes

Asthma Phenotypes in the Inner City

Open-Label, Safety Study Evaluating the Use of Dexmedetomidine in Pediatric Subjects Undergoing Procedure-Type Sedation

Comparison of NN5401 With Insulin Glargine, Both in Combination With Oral Antidiabetic Drugs, in Subjects With Type 2 Diabetes

Phase 4 Gastrointestinal Tolerability Study of Dimethyl Fumarate in Patients With Relapsing Forms of Multiple Sclerosis in the United States

Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes

Biomarker-based Cockroach Sublingual Immunotherapy Study (BioCSI)

The Effect of Diflunisal on Familial Amyloidosis

A Phase I/II Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Gemcitabine in Cancer Patients

Switching Drug Therapy for the Prevention of Blood Clot Formation From Enoxaparin to Rivaroxaban After Orthopedic Surgery for Either Total Hip or Total Knee Replacement